205
Participants
Start Date
May 28, 2020
Primary Completion Date
October 17, 2022
Study Completion Date
October 17, 2022
JUVÉDERM® VOLUMA® XC
JUVÉDERM® VOLUMA® XC injectable gel
No-treatment control
Participants received no treatment for 3 months during the Control Period.
Williams Plastic Surgery Specialists /ID# 232789, Latham
Hevia Cosmetic Dermatology /ID# 232824, Coral Gables
Steven Fagien MD PA /ID# 232807, Boca Raton
Bradenton Dermatologist /ID# 232822, Bradenton
The Practice of Brian S. Biesman MD PLLC /ID# 232662, Nashville
Delricht Research /ID# 233142, New Orleans
Dallas Plastic Surgery Institute /ID# 232971, Dallas
Skin Care and Laser Physicians of Beverly Hills /ID# 232967, Los Angeles
Steve Yoelin MD Medical Associate Inc /ID# 232956, Newport Beach
Skin and Cancer Associates, LLP /ID# 232923, Miami
Research Institute of the Southeast, LLC /ID# 233144, West Palm Beach
Callender Center for Clinical Research /ID# 233167, Glenn Dale
Skincare Physicians /ID# 233054, Chestnut Hill
Aesthetic Solutions /ID# 232953, Chapel Hill
Jose Raul Montes Eyes & Facial Rejuvenation-Torre Medica Aux /ID# 232706, San Juan
Lead Sponsor
Allergan
INDUSTRY